Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

JMACW

Maxpro Capital Acquisition (JMACW)

Maxpro Capital Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:JMACW

Date	Heure	Source	Titre	Symbole	Société
13/01/2023	22h13	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
10/01/2023	22h05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
15/11/2022	14h00	GlobeNewswire Inc.	Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
14/09/2022	14h30	GlobeNewswire Inc.	Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
26/11/2021	15h00	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
14/10/2021	00h03	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
08/10/2021	00h41	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation